Danaher to Present at TD Cowen Health Care Conference
Danaher (NYSE: DHR) announced that President and CEO Rainer M. Blair will present at the TD Cowen Healthcare Conference in Boston on March 3, 2025 at 1:50 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Danaher (NYSE: DHR) announced that President and CEO Rainer M. Blair will present at the TD Cowen Healthcare Conference in Boston on March 3, 2025 at 1:50 p.m. ET. The presentation will be webcast and accessible via Danaher's Investors site under Events & Presentations.
Details
News Market Reaction – DHR
On Feb 25, the first trading day after this news, DHR closed 0.16% above the previous close.
Data tracked by StockTitan Argus for the Feb 25 session.
Key Figures
- Conference date
- March 3, 2025
- TD Cowen Healthcare Conference presentation date
- Presentation time
- 1:50 p.m. ET
- Scheduled time for Danaher CEO’s conference presentation
Historical Context
-
Announced cash acquisition of Masimo for $180 per share, totaling $9.9B.
-
Detailed Masimo EBITDA, synergy targets, and expected EPS accretion from the acquisition.
-
Reported revenue and EPS growth, strong cash flow, and introduced FY2026 guidance range.
-
CEO previewed Q4 revenue and EPS near high end of prior guidance.
-
Announced CEO presentation and webcast access at J.P. Morgan Healthcare Conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 60,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/danaher-to-present-at-td-cowen-health-care-conference-302696210.html
SOURCE Danaher Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.